| Identification | |
| Name: | Ritonavir |
| Synonyms: | 2,4,7,12-Tetraazatridecan-13-oicacid,10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-,5-thiazolylmethyl ester, (5S,8S,10S,11S)- (9CI);A 84538;ABT 538;Abbott84538;NSC 693184;Norvir; |
| CAS: | 155213-67-5 |
| Molecular Formula: | C37H48N6O5S2 |
| Molecular Weight: | 720.94 |
| InChI: | InChI=1/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32?,33?/m0/s1 |
| Molecular Structure: |  |
| Properties | |
| Density: | 1.239 g/cm3 |
| Refractive index: | 1.599 |
| Solubility: | Freely soluble in methanol and ethanol; soluble in isopropanol. In water, 1.1X10-4 mg/L @ 25 deg C /Estimated/ |
| Appearance: | white powder |
| Specification: |
?Ritonavir , its cas register number is 155213-67-5. It also can be called Ritonavir [USAN] ;? 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate ;? 5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate ; 2,4,7,12-Tetraazatridecan-13-oic acid, 10-hydroxy-2-methyl-5-(1-methylethyl)-1-(2-(1-methylethyl)-4-thiazolyl)-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (5S-(5R*,8R*,10R*,11R*))- .It is a?white powder. |
| Color: | White to light tan powder |
| Usage: | A selective HIV protease inhibitor |
| Safety Data | |
 |
|
